We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Settles With Second Florida Clinic in HIV PrEP Drug Counterfeit Case
Gilead Settles With Second Florida Clinic in HIV PrEP Drug Counterfeit Case
Gilead Sciences has reached a $33 million settlement with a Florida clinic accused of fraudulently applying to the company’s patient assistance program via homeless people and those in low-wage jobs in order to get access to Gilead’s pricey human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) drugs for free, then selling them on the black market.